BIOMAT Database Logo BIOMAT Database Logo

Raynaud's phenomenon and positive antinuclear antibodies in a malignancy. 1990

C Tolosa-Vilella, and J Ordi-Ros, and M Vilardell-Tarres, and A Selva-O'Callaghan, and R Jordana-Comajuncosa
Department of Internal Medicine, Vall d'Hebron' Hospital, Barcelona, Spain.

Both Raynaud's phenomenon and the presence of antinuclear antibodies are uncommon features of malignant disease and the association of both with a malignancy extremely rare. The case is reported of a 78 year old woman who presented with Raynaud's phenomenon and positive antinuclear antibodies related to adenocarcinoma of unknown primary site.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D009382 Neoplasms, Unknown Primary Metastases in which the tissue of origin is unknown. Neoplasm Metastasis, Unknown Primary,Neoplasms, Occult Primary,Occult Primary Neoplasms,Unknown Primary Tumors,Unknown Primary Neoplasm Metastasis,Unknown Primary Neoplasms,Neoplasm, Occult Primary,Neoplasm, Unknown Primary,Occult Primary Neoplasm,Primary Neoplasm, Occult,Primary Neoplasm, Unknown,Primary Neoplasms, Occult,Primary Neoplasms, Unknown,Primary Tumor, Unknown,Primary Tumors, Unknown,Tumor, Unknown Primary,Tumors, Unknown Primary,Unknown Primary Neoplasm,Unknown Primary Tumor
D011928 Raynaud Disease An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress. Cold Fingers, Hereditary,Raynaud Phenomenon,Raynaud's Disease,Raynauds Disease
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000974 Antibodies, Antinuclear Autoantibodies directed against various nuclear antigens including DNA, RNA, histones, acidic nuclear proteins, or complexes of these molecular elements. Antinuclear antibodies are found in systemic autoimmune diseases including systemic lupus erythematosus, Sjogren's syndrome, scleroderma, polymyositis, and mixed connective tissue disease. Anti-DNA Antibodies,Antibodies, Anti-DNA,Antinuclear Antibodies,Antinuclear Autoantibodies,Antinuclear Autoantibody,Antinuclear Factors,Antinuclear Antibody,Antinuclear Factor,Anti DNA Antibodies,Antibody, Antinuclear,Autoantibody, Antinuclear,Factor, Antinuclear

Related Publications

C Tolosa-Vilella, and J Ordi-Ros, and M Vilardell-Tarres, and A Selva-O'Callaghan, and R Jordana-Comajuncosa
Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies.
August 1982, Annals of the rheumatic diseases,
C Tolosa-Vilella, and J Ordi-Ros, and M Vilardell-Tarres, and A Selva-O'Callaghan, and R Jordana-Comajuncosa
Antinuclear antibodies in scleroderma, mixed connective tissue disease and "primary" Raynaud's phenomenon.
March 1988, Clinical rheumatology,
C Tolosa-Vilella, and J Ordi-Ros, and M Vilardell-Tarres, and A Selva-O'Callaghan, and R Jordana-Comajuncosa
[Prognostic factors in Raynaud's phenomenon: usefulness of antinuclear antibodies and of periungual capillaroscopy].
January 1990, Medicina (Florence, Italy),
C Tolosa-Vilella, and J Ordi-Ros, and M Vilardell-Tarres, and A Selva-O'Callaghan, and R Jordana-Comajuncosa
Raynaud's phenomenon together with antinuclear antibodies: a common subset of incomplete connective tissue disease.
May 1995, Journal of the American Academy of Dermatology,
C Tolosa-Vilella, and J Ordi-Ros, and M Vilardell-Tarres, and A Selva-O'Callaghan, and R Jordana-Comajuncosa
Gemcitabine-induced hemolytic uremic syndrome mimicking scleroderma renal crisis presenting with Raynaud's phenomenon, positive antinuclear antibodies and hypertensive emergency.
January 2014, Internal medicine (Tokyo, Japan),
C Tolosa-Vilella, and J Ordi-Ros, and M Vilardell-Tarres, and A Selva-O'Callaghan, and R Jordana-Comajuncosa
[Raynaud's phenomenon and anticentromere antibodies].
November 1987, Medicina clinica,
C Tolosa-Vilella, and J Ordi-Ros, and M Vilardell-Tarres, and A Selva-O'Callaghan, and R Jordana-Comajuncosa
Malignant pheochromocytoma associated with Jaccoud's-type arthropathy, Raynaud's phenomenon, positive antinuclear antibody and rheumatoid factor.
September 1994, Gaoxiong yi xue ke xue za zhi = The Kaohsiung journal of medical sciences,
C Tolosa-Vilella, and J Ordi-Ros, and M Vilardell-Tarres, and A Selva-O'Callaghan, and R Jordana-Comajuncosa
Raynaud's phenomenon and positive antinuclear antibodies as first manifestation of POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes): a case report.
May 2022, BMC rheumatology,
C Tolosa-Vilella, and J Ordi-Ros, and M Vilardell-Tarres, and A Selva-O'Callaghan, and R Jordana-Comajuncosa
Malignancy associated with antinuclear antibodies.
December 1972, Lancet (London, England),
C Tolosa-Vilella, and J Ordi-Ros, and M Vilardell-Tarres, and A Selva-O'Callaghan, and R Jordana-Comajuncosa
Malignancy associated with antinuclear antibodies.
November 1972, Lancet (London, England),
Copied contents to your clipboard!